Meridian Bioscience reported $26.07M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 158M
Accelerate Diagnostics AXDX:US 10.67M 819K
Atrion ATRI:US 8.01M 1.09M
Becton, Dickinson and BDX:US $ 1.23B 9M
Bio Rad Laboratories BIO:US $ 197.39M 28.15M
Cerulean Pharma CERU:US $ 2.59M 168.34K
Cerus CERS:US $ 20.74M 1.27M
Meridian Bioscience VIVO:US $ 26.07M 3.67M
Myriad Genetics MYGN:US $ 110.6M 33.3M
Orasure Technologies OSUR:US $ 31.87M 4.31M
Quidel QDEL:US $ 89.9M 11.19M
Sientra SIEN:US 25.8M 3.24M
Staar Surgical STAA:US $ 29.21M 674K
Thermo Fisher Scientific TMO:US $ 2.28B 157M
Trinity Biotech TRIB:US 6.13M 572K
Utah Medical Products UTMD:US 2.85M 81K